Drug Topics
AUGUST 23, 2023
Predisposing factors contributing to development of acne in both groups were the use of concomitant medications associated with acne, family history of acne, and a medical history of acne.
PharmaVoice
AUGUST 23, 2023
The HeLa cell line’s contributions to medical science were obtained without permission, and now biotechs profiting from its use are answering for it.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 23, 2023
One in 5 women report mistreatment during maternity care, employers see rise in mental health challenges, and Microsoft teams up with Epic to increase the use of AI in healthcare.
Pharmacy Times
AUGUST 23, 2023
By embracing collaboration, optimizing work hours, and prioritizing patient care, pharmacy technicians are leading the charge towards an inclusive, technologically advanced, and patient-focused era in pharmaceutical practice.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
AUGUST 23, 2023
Health plans would play a vital role in extending Medicaid benefits to include housing, a possibility that’s gotten a boost from certain initiatives by the Biden administration, according to
Pharmacy Times
AUGUST 23, 2023
Relapses of MIS-C occurred in 2 patients due to rapid tapering of corticosteroids at 2 weeks instead of the standard protocol of 4 to 6 weeks.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 23, 2023
Generative artificial intelligence is a type of self-learning software that can increase the time pharmacists can allocate to patients, improve medication adherence, and allow patients to access health data on a whim.
STAT
AUGUST 23, 2023
Of the 103 million confirmed cases of Covid-19 in the U.S., an estimated one-third have led to long Covid — a condition that ranges in severity, but can be debilitating. A new study suggests that even more people may be suffering from the post-viral syndrome without having ever received an official diagnosis of Covid-19. The study , published Wednesday in Neurology, Neuroimmunology & Neuroinflammation , was small, examining only 29 patients.
Pharmacy Times
AUGUST 23, 2023
Kristin Glezman, PharmD, owner and pharmacist in charge of the independent pharmacy in Denison, Texas, takes pride in caring for the local community.
STAT
AUGUST 23, 2023
The number of gender-affirming surgeries taking place in the U.S. nearly tripled between 2016 and 2019, according to new national estimates from a cohort study in JAMA Network Open. Over 48,000 people got some type of gender-affirming surgery between 2016-2020, with a slight decrease in the number of surgeries performed in 2020, likely because of the pandemic.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
AUGUST 23, 2023
The drug showed statistically significant and clinically meaningful efficacy results across key subgroups.
STAT
AUGUST 23, 2023
Treatment of obesity has never been more prominent, with the advent of medications like Ozempic and Mounjaro generating both excitement and concern. Overlooked, however, is a severe shortage of doctors who actually specialize in treating obesity. Across the United States, fewer than 100 doctors have completed a fellowship in obesity medicine and are actively practicing, according to a STAT analysis.
Fierce Healthcare
AUGUST 23, 2023
The healthcare industry has suffered fewer but larger cybersecurity breaches in the first half of 2023, suggesting a shift in targets and tactics among attackers, wrote cybersecurity firm Critical | An analysis of 308 reported data breaches suggests cyberattackers have shifted their focus from email phishing to network servers as well as to vulnerabilities in the healthcare supply chain.
STAT
AUGUST 23, 2023
Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm, offering early access to new startups formed by serial biotech entrepreneur Bob Langer. Former Pear CEO Corey McCann and former licensing head Michael Langer formed the new firm, T.rx Capital, earlier this year, according to three people with knowledge of the firm and documents reviewed by STAT.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
AUGUST 23, 2023
Revive has begun the development of a next-generation formulation of Bucillamine to treat public health emergencies.
STAT
AUGUST 23, 2023
To most people on the planet, the Covid-19 pandemic is over. But for many scientists who have been tracking the largest global infectious disease event in the era of molecular biology, there is still a step that the virus that caused it, SARS-CoV-2, hasn’t yet taken. It has not fallen into a predictable seasonal pattern of the type most respiratory pathogens follow.
European Pharmaceutical Review
AUGUST 23, 2023
Eli Lilly and Company ’s highly selective and potent RET kinase inhibitor for advanced medullary thyroid cancer (MTC) has demonstrated superior progression-free survival (PFS) compared to approved multikinase inhibitors. These topline results are from an interim efficacy analysis of a Phase III study that compared Retevmo ® (selpercatinib) against multikinase inhibitors (MKIs) cabozantinib or vandetanib.
STAT
AUGUST 23, 2023
The youngest candidate on Wednesday night’s debate stage didn’t make any friends among his fellow Republican presidential hopefuls, questioning their morality, mocking their promises, and suggesting that he, by virtue of his inexperience in government, was ideally suited to solve a nation’s problems. For Vivek Ramaswamy, it was familiar territory.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
AUGUST 23, 2023
EHR giant Epic unveiled Tuesday new third-party vendor programs to replace the app market it shut down late last year. | The company has now developed four programs for third-party vendors that will be available in the 'showroom': cornerstone partners, pals, partners and member services.
STAT
AUGUST 23, 2023
An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation. The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.
PharmExec
AUGUST 23, 2023
Program designed to aid life science organizations in improving go-to-market strategy.
STAT
AUGUST 23, 2023
The multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target has had no shortage of twists and tea-leaf- reading. In the wee hours of Wednesday morning, it got another. Roche confirmed it accidentally released interim data from a closely watched clinical trial testing whether blocking that target — a protein on T cells known as TIGIT — can enable non-small lung cancer patients to live longer than standard immunotherapy alone.
Drug Store News
AUGUST 23, 2023
The retail partnership will consist of seven color depositing masks in trending shades, as well as a clear glossing treatment.
STAT
AUGUST 23, 2023
In recent weeks, you may have seen alarming headlines about how leprosy might become “endemic” in Florida. As a physician in Florida who specializes in treating leprosy, also known as Hansen’s disease, this case report was not “news” to us in the field: We have known for some time about endemic cases of leprosy. However, given how rare the disease is in the state, there is no cause for alarm — despite the fearful headline.
European Pharmaceutical Review
AUGUST 23, 2023
Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents, proposed by the USP Microbiology Expert Committee, is now published as a General Announcement. This is in advance of the official open comment period, according to USP. Comments are welcome from 1 November 2023 to 31 January 2024. The new standard was proposed by the committee earlier in 2023.
STAT
AUGUST 23, 2023
Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause of severe eye inflammation reported in patients receiving the treatment — but the company stopped short of definitively linking the needle to the cases.
The Checkup by Singlecare
AUGUST 23, 2023
Constipation is common, but that doesn’t make it any less uncomfortable. You’ll understand the desire for quick relief if you’ve ever experienced bloating, straining to poop, or passing hard, lumpy stools. About 16% of American adults experience constipation , and the number is even higher (33%) in adults 60 or older. What you eat also significantly impacts the frequency and ease of going to the bathroom.
STAT
AUGUST 23, 2023
Hello and happy Wednesday from STAT’s London outpost, with Andrew Joseph here filling in for Ed. While you fire up the coffee pot, we’re doing a bit of post-lunch cleanup, but still of course have time to offer you the latest in pharma headlines. In the wee hours of Wednesday morning, the multibillion-dollar hunt for what many drugmakers hope will be the next big immunotherapy target had its latest twist , STAT details.
pharmaphorum
AUGUST 23, 2023
US sets aside $1.4bn for COVID as new variant emerges Phil.
STAT
AUGUST 23, 2023
The Food and Drug Administration recently approved Opill , the first over-the-counter access birth control pill , in a monumental and long overdue win for reproductive and public health care. This FDA ruling will significantly expand access to high-quality contraception for folks across the country. However, true access will require affordability, too.
pharmaphorum
AUGUST 23, 2023
Leo builds dermatology pipeline with Timber deal Phil.
Hospital Pharmacy Europe
AUGUST 23, 2023
Mitazalimab has received orphan drug designation status by the European Medicines Agency (EMA) for the treatment of patients with pancreatic cancer, its manufacturer Alligator Bioscience has announced. A human CD40 agonistic antibody targeting CD40, mitazalimab kickstarts the cancer-immunity cycle by priming and activating tumour-specific T cells. Targeting CD40 with mitazalimab has the potential to augment responses to chemotherapy.
Fierce Healthcare
AUGUST 23, 2023
There has been record demand for youth mental health services in the past few years. U.S. | Daybreak Health aims to advance access and equity to mental health resources for youth across the country by focusing on the place they spend the majority of their time — school.
Expert insights. Personalized for you.
247 
Let's personalize your content